Pathophysiological Aspects of Proteases in Cancer

Table of Contents

Section I: General Aspects
1. Pathophysiological aspects of calpains in cancer
2. Mitochondrial proteases in cancer development and progression
3. Proteases in Head and Neck Cancer
4. Matrix metalloproteases and uveal melanomas
5. Proteases in DNA damage, repair and radio resistance: Cellular and Molecular aspects
6. Radiotherapy, proteases and gastric cancer: a complex interplay
7. Matrix metalloproteases in the pathogenesis of hepatocarcinoma
8. Exploring synthetic and natural compounds for Cathepsin B: Mechanisms and therapy
9. Kallikrein-related peptidase 3 (KLK3) as valuable biomarkers for prostate cancer
10. Ubiquitin -specific protease 3,7 in bone cancer and squamous cell carcinoma
11. Serine protease: structure, classification, mechanism and role in breast cancer

Section II: Proteases as Diagnostics and Prognostics Biomarkers
12. Protease activator receptor-1 and matrix metalloproteinase-1 as prognostic factors and novel therapeutic targets for gastric cancer
13. Matrix metalloproteases as diagnostic and prognostic biomarkers in cancer
14. From enzyme to predictors: Serine proteases in cancer diagnosis and prognosis
15. Cathepsins as a diagnostic and prognostic marker in Oral cancer
16. Role of Kallikreins in Prostate Cancer
17. Mechanistic aspects of Serine Protease as biomarkers in wound healing of lung cancer
18. The role of acetylcholinesterase in cancer development and possible therapeutic applications
19. Therapeutics of animal derived compounds in proteases induced cancer
20. Molecular Warriors: Proteases as Sentinels in the War Against Cancer Diagnosis and Prognosis

Section III: Proteases, Chemoresistance and Cancer
21. Serine proteases, chemoresistance and cancer
22. Cathepsins, chemoresistance and cancer
23. ix metalloproteases, chemoresistance and cancer
24. MMPs (-2 and -9) mediated drug resistance and their reversal in gynecological cancer
25. The link between trypsinogen and chymotrypsinogen in gastrointestinal cancer
26. Role of the proteasome in the development of chemoresistance in multiple myeloma
27. Role of cysteine cathepsin and matrix metalloproteases in progression and chemoresistance in ovarian and breast cancer
28. Proteases, chemoresistance and cancer
29. Breaking Barriers: Proteases as Key Players in Cancer Chemoresistance

Section IV: Other Aspects
30. Matrix metalloproteases-targeting low molecular weight compound
31. Synthetic protease inhibitors in oral, head and neck cancer: evidence from clinical trials.
32. Synthetic protease inhibitors in endocrine and gastroenterology cancers: results of clinical trials
33. Side effects of synthetic protease inhibitors used in gynecology cancers
34. Role of synthetic compounds with protease inhibitory activity in breast cancer
35. Cathepsin responsive nanomaterials for targeted delivery of malignant tumors

Authors

Sajal Chakraborti Professor, Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, India. Dr. Sajal Chakraborti, PhD, DSc is a Professor at the Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India. He did post-doctoral research at the Johns Hopkins Medical Institution, Baltimore; New York Medical College, New York; the University of Utah Health Sciences Center, Salt Lake City, Utah; and the University of Florida, Gainesville, Florida. He has over 35 years teaching and independent research experience in Biochemistry, Molecular Physiology and Cell Biology. He has published over 110 original research articles, dozens of review articles and book chapters, and also edited twelve books. Srijit Das Professor of Anatomy, Department of Human and Clinical Anatomy, Sultan Qaboos University, Oman. Dr. Srijit Das is currently Professor of Anatomy at the Sultan Quaboos University in Oman. He has decades teaching experience in Anatomy including Embryology, Histology, Gross Anatomy, Neuroanatomy, Radiological Anatomy, Clinical Anatomy, and Surface Anatomy. He is member of World Association of Medical Editors. He published 500 articles in world-renowned journals, published 5 books and is editorial board member of numerous globally respected journals. Cheorl-Ho Kim Professor and Chair, Department of Biological Sciences, College of Science, Sungkyunkwan University and Samsung Advanced Institute of Health Science and Technology (SAIHST), Korea. Prof/Dr Cheorl-Ho Kim has received his MS and PhD in The University of Tokyo during the period of 1985-1990. Currently, since 2006 he is professor and chair of Department of Biological Sciences, College of Science, Sungkyunkwan University and Samsung Advanced Institute of Health Science and Technology (SAIHST), Korea. He has successfully completed his Administrative responsibilities as Genome Program Head, Korea Research Institute of Bioscience and Biotechnology on 1990-1996 and Chairman, Department of Biochemistry and Molecular Biology, College of Oriental Medicine, Dongguk University during 1996-2006. His research has included the molecular biology of gene expression, ER-Golgi glycosyltransferases, oncogenesis, cancer metastasis and angiogenesis. He has authored more than 350 research articles/books with H-index 66. He is a member of International Scientific Advisory Board Member, International Symposium for Glycosyltransferases (GlycoT 2006), IUBMB symposium, Tsukuba and International Symposium for Glycosyltransferases (GlycoT 2008), Emory University, GA, USA, 2010 Tokai University GlycoResearch Center and 2015 Visiting Professor, The Ohio State University